Homologous and heterologous antibodies to coronavirus 229E, NL63, OC43, HKU1, SARS, MERS and SARS-CoV-2 antigens in an age stratified cross-sectional serosurvey in a large tertiary hospital in The Netherlands
Westerhuis, B. M.; de Bruin, E.; Chandler, F. D.; Ramakers, C. R. B.; Okba, N. M. A.; Li, W.; Goossens, H.; de Jong, M. D.; Bosch, B. J.; Haagmans, B. L.; Fraaij, P. L.; Sikkema, R. S.; Koopmans, M. P. G.
Show abstract
Understanding the coronavirus (CoV) antibody landscape in relation to disease and susceptibility is critical for modelling of steps in the next phase during the current covid-19 pandemic. In March 2020, during the first month of the epidemic in The Netherlands, we performed cross sectional studies at two time points amongst patients of the Erasmus Medical Centre in Rotterdam, to assess the presence of antibodies against seasonal human coronaviruses (OC43, 229E, NL63, HKU1), emerging zoonotic coronaviruses (SARS, MERS) and SARS-CoV-2 in nine different age groups. We observed minimal SARS-CoV-2 reactivity early March (0.7% of sera), increasing to 3.0%, four weeks later, suggesting probably undetected cases during this early phase of the epidemic. Antibody responses were mostly coronavirus species specific at young age, but possible cross-reactivity between human seasonal CoVs was observed with increasing age.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1) 92%
- Longitudinal trends in the endemic symptomatic burden of COVID-19: Insights from community-based participatory virological surveillance in the Netherlands, November 2020 - April 2025 90%
- Prevalence of IgG and IgM to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone and Uganda: A Longitudinal Study 89%
Similar papers in this journal
- The effect of pre-existing coronavirus antibodies on SARS-CoV-2 infection outcomes in exposed household members 93%
- SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali 90%
- SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunity 90%
Similar papers in this journal
- SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy 90%
- Kinetics and seroprevalence of SARS-CoV-2 antibodies – a comparison of 3 different assays 90%
- Results of an early second PCR test performed on SARS-CoV-2 positive patients may indicate risk for severe COVID-19 89%
Similar papers in this journal
- Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent Covid-19 – a prospective multicentre cohort study 90%
- Potential impact of individual exposure histories to endemic human coronaviruses on age-dependence in severity of COVID-19 90%
- Antibody Conversion rates to SARS-CoV-2 in Saliva from Children Attending Summer Schools in Barcelona, Spain 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.